Daiwei Wan
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 6
- Wnt/β-catenin signaling in development and cancer 2
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 4
- Co-authors
- Qiaoming Zhi (15 shared papers)Dingcheng Zheng (3 shared papers)Songbing He (5 shared papers)Dechun Li (2 shared papers)Min Fei (2 shared papers)Songbing He (10 shared papers)Ye Han (9 shared papers)Liang Wang (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (5 papers)Frontiers in Oncology (3 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Daiwei Wan
25 papers receiving 752 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 292
- Oncology 187
- Molecular Biology 424
- Immunology 117
- Toxicology 12
Countries citing papers authored by Daiwei Wan
This map shows the geographic impact of Daiwei Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiwei Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiwei Wan more than expected).
Fields of papers citing papers by Daiwei Wan
This network shows the impact of papers produced by Daiwei Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiwei Wan. The network helps show where Daiwei Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daiwei Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 118 | |
| 2 | 2019 | 75 | |
| 3 | 2016 | 63 | |
| 4 | 2014 | 55 | |
| 5 | 2018 | 49 | |
| 6 | 2016 | 43 | |
| 7 | 2014 | 41 | |
| 8 | 2013 | 40 | |
| 9 | 2017 | 34 | |
| 10 | 2020 | 33 | |
| 11 | 2018 | 28 | |
| 12 | 2014 | 27 | |
| 13 | 2013 | 21 | |
| 14 | 2021 | 19 | |
| 15 | 2018 | 17 | |
| 16 | 2014 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2019 | 14 | |
| 19 | 2017 | 14 | |
| 20 | 2024 | 10 |
About Daiwei Wan
Daiwei Wan is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 25 papers that have together received 754 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Cells and Metastasis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (292 citations), Oncology (187 citations), Molecular Biology (424 citations), Immunology (117 citations) and Toxicology (12 citations). Daiwei Wan has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Qiaoming Zhi, Dingcheng Zheng, Songbing He, Dechun Li, Min Fei, Songbing He, Ye Han, Liang Wang, Yugang Wu and Zhihua Xu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Frontiers in Oncology, Anti-Cancer Agents in Medicinal Chemistry, Molecular Cancer Therapeutics and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.